decisionhealth Newsletters, Coder Pink Sheets - 2004 Issue 11 (November)
National prescription database may be law by year's end
Subscribe or sign in to view the full article.
Article Overview
This article covers proposed U.S. legislation affecting prescription drug monitoring programs, with emphasis on federal support for state-level systems, interstate information sharing, and the policy issues that shaped the debate. It is relevant to pain physicians, pharmacists, compliance professionals, and health policy readers who follow controlled-substance monitoring and prescription fraud prevention. The article also touches on the roles of Congress, the Department of Health and Human Services, and state participation in these monitoring efforts.
Why This Topic Matters
The topic matters because prescription monitoring policy can affect how controlled substances are tracked across states, how providers and pharmacies respond to suspected misuse, and how state and federal programs are funded and coordinated. It also highlights privacy concerns and implementation issues that influence whether such systems are adopted and how broadly they function.
Article Sections
-
Federal legislation and congressional action
Introduces the proposed bill and summarizes its status in Congress. It also frames the policy purpose behind the legislation and the organizations and lawmakers involved.
-
State prescription monitoring programs and interstate tracking
Explains the general structure of state-run prescription monitoring efforts and how data sharing across state lines is intended to work. It also describes the broader rollout of these programs across the states.
-
State participation, privacy concerns, and funding incentives
Describes the conditions tied to state participation, including oversight by federal health authorities and concerns about privacy. It also discusses funding incentives and the policy pressures affecting adoption.
What You Will Learn
- How proposed federal legislation relates to state prescription monitoring systems
- What broad policy issues affect prescription drug tracking programs
- Why interstate data sharing is a key part of the discussion
- How privacy and funding concerns influence state participation
Who Should Read This
- Pain physicians
- Pharmacists
- Healthcare compliance professionals
- Medical coders and auditors with policy interests
- Health policy analysts
Subscribe or sign in to view the full article.


Quick, Current, Complete - www.findacode.com